Profile
Gunnar F.
Kaufmann worked as Senior VP-Immunotherapy & Head-Research at Sorrento Therapeutics, Inc. from 2012 to 2019.
He then worked as Chief Scientific Officer at Oncternal Therapeutics, Inc. from 2019 to 2023.
Kaufmann holds a doctorate degree from The Scripps Research Institute, an undergraduate degree from Philipps University of Marburg, and a graduate degree from the University of Greifswald.
Former positions of Gunnar Kaufmann
| Companies | Position | End |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-06-13 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-08-31 |
Training of Gunnar Kaufmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Greifswald
University of Greifswald Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Gunnar Kaufmann
















